Myeloproliferative Neoplasms and Critical Limb Ischemia: New Insights —In a new study, revascularization reduced major adverse cardiovascular and limb events (MACLE) and amputations, but it ...

A new statement from leading heart and blood vessel experts in Europe is providing clinical guidance for treatments to ...

There are high, 2-year rates of amputation-free survival and limb salvage among patients with no-option CLTI who receive TADV.

Acute or chronic upper limb ischemia is an uncommon condition [1,2,3] that is responsible for between 15 and 18% of the procedures undertaken for critically ischemic limbs. [4,5] Thromboembolic ...

A new statement from leading heart and blood vessel experts in Europe is providing clinical guidance for treatments to ...

Watch the video Click the White paper STENTiT Enrolls First Patient in Clinical TrialEvaluating a Novel Stent with ...

Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and ...

Acute or chronic upper limb ischemia is an uncommon condition [1,2,3] that is responsible for between 15 and 18% of the procedures undertaken for critically ischemic limbs. [4,5] Thromboembolic ...

Breakthrough procedure reduces amputation risk for patients with Chronic Limb-Threatening Ischemia We're not only ...

A groundbreaking multinational clinical trial, named RESILIENCE, is underway to test a promising new treatment aimed at ...

A new statement from leading heart and blood vessel experts in Europe is providing clinical guidance for treatments to prevent blood clots in patients with a serious condition called chronic limb ...

Discussion. The true incidence of upper limb ischemia is difficult to assess because patients treated conservatively are rarely identified and most figures are derived from published surgical ...